Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Neuroscience Institute

Total Results:

13460


Local phase coherence and the perception of blur

Wang, Zhou; Simoncelli, Eero P
ORIGINAL:0008283
ISSN: 1049-5258
CID: 371232

Patients at the center: in our practice, and in our use of language [Letter]

Goldfarb, David S
PMID: 15122848
ISSN: 1056-8751
CID: 155992

GJB2 gene mutations in cochlear implant recipients: prevalence and impact on outcome

Lustig, Lawrence R; Lin, Doris; Venick, Holly; Larky, Jan; Yeagle, Jennifer; Chinnici, Jill; Polite, Colleen; Mhatre, Anand N; Niparko, John K; Lalwani, Anil K
OBJECTIVE: To determine the prevalence of GJB2 gene mutations in patients undergoing cochlear implantation (CI) and their impact on rehabilitative outcome following implantation. DESIGN: Prospective determination of GJB2 mutation by sequence analysis by denaturing high-performance liquid chromatography and its correlation with outcome following CI. SETTINGS: Two tertiary academic medical centers. PATIENTS: Subjects who have met the audiologic criteria and have undergone CI. RESULTS: Of 77 cochlear implant recipients screened, 13 (18%) harbored a detectable sequence alteration in the GJB2 gene. Only 3 of these 13 patients had hearing loss clearly attributable to a biallelic GJB2 mutation. There were 2 patients with homozygous mutations, including a 35delG and a 167delT mutation, and a third with a compound heterozygous mutation. Of the remaining 10 patients, 8 had 1 deafness allele, while 2 had a normal polymorphism that was not believed to be implicated in the hearing loss. Six patients had the common 35delG mutation: 5 patients had heterozygous mutations, which are probably not related to the underlying hearing loss (a second deafness allele cannot be ruled out in these cases because of the screening methodology used), while 1 patient had a homozygous mutation, which was clearly implicated in the patient's deafness. Rehabilitative outcome among those with detectable sequence alterations, as well as the 3 patients with biallelic mutations, varied but were similar on average when compared with outcomes seen in our entire CI population. CONCLUSIONS: A large percentage of implant candidates harbor mutations or sequence alterations in the GJB2 gene, although only a small number of these changes are biallelic and a clear cause of the hearing loss. These results demonstrate that patients with GJB2-related deafness clearly benefit from CI
PMID: 15148174
ISSN: 0886-4470
CID: 45378

Multiple neural spike train data analysis: state-of-the-art and future challenges

Brown, Emery N; Kass, Robert E; Mitra, Partha P
Multiple electrodes are now a standard tool in neuroscience research that make it possible to study the simultaneous activity of several neurons in a given brain region or across different regions. The data from multi-electrode studies present important analysis challenges that must be resolved for optimal use of these neurophysiological measurements to answer questions about how the brain works. Here we review statistical methods for the analysis of multiple neural spike-train data and discuss future challenges for methodology research
PMID: 15114358
ISSN: 1097-6256
CID: 143193

DAncing past the DAT at a DA synapse

Cragg, Stephanie J; Rice, Margaret E
PMID: 15111009
ISSN: 0166-2236
CID: 45310

Long-term auditory adaptation to a modified peripheral frequency map

Neuburger, H; Silveira, A; Svirsky, M A; Suarez, H; Teoh, Su-Wooi
OBJECTIVE: Cochlear implants (CIs) attempt to mimic the tonotopicity of the normal ear by stimulating more basal regions of the cochlea in response to higher frequencies. However, there may be a mismatch between the normal place-frequency map and that implemented by a CI. MATERIAL AND METHODS: Aiming to measure this potential mismatch and its changes over time, the present study used a method-of-adjustment procedure where CI users and normal-hearing listeners selected synthetic vowels to match prespecified vowel targets. Data from CI users were obtained longitudinally, starting on the day of initial stimulation and continuing for 2 years. RESULTS: CI users showed a significant amount of initial mismatch with respect to the normal-hearing listeners, but they also showed significant learning and adaptation over time and achieved nearly normal performance after some experience with the CI. CONCLUSION: In general, the adaptation process took several months, suggesting that some CI users may benefit from alternative signal processing or rehabilitation procedures designed to facilitate perceptual learning after cochlear implantation
PMID: 15224858
ISSN: 0001-6489
CID: 67960

Lipid metabolism in phosphatidylinositol transfer protein alpha-deficient vibrator mice

Monaco, Marie E; Kim, James; Ruan, WeiFeng; Wieczorek, Rosemary; Kleinberg, David L; Walden, Paul D
Mice that are homozygous for the vibrator mutation express 65-85% less phosphatidylinositol transfer protein alpha (PITPalpha) than their wild type litter mates. By postnatal day 10-12 (P10-12) they exhibit signs of neurodegeneration and die prematurely by P40. In the present study, we examine the lipid content of brain, liver, and mammary glands from these animals. Lipid-mediated signal transduction is evaluated in primary fibroblast cultures. With respect to the lipid make-up of brain and liver, we report that there is a significant increase (2- to 4-fold) in the neutral lipids present in the livers of vb/vb animals when compared with wild type (+/+) litter mates. No significant changes are observed in the brains of these animals. The mammary glands of vb/vb mice are underdeveloped with respect to ductal and alveolar structures, and the fat pad is composed of predominantly brown adipose tissue rather than the white adipose tissue characteristic of age-matched wild type litter mates. No differences are observed in any aspect of lipid-mediated signal transduction
PMID: 15063778
ISSN: 0006-291x
CID: 44926

Activity-dependent phosphorylation of tyrosine hydroxylase in dopaminergic neurons of the rat retina

Witkovsky, Paul; Veisenberger, Eleonora; Haycock, John W; Akopian, Abram; Garcia-Espana, Antonio; Meller, Emanuel
We studied in vivo activity-dependent phosphorylation of tyrosine hydroxylase (TH) in dopaminergic (DA) neurons of the rat retina. TH phosphorylation (TH-P) was evaluated by immunocytochemistry, using antibodies specific for each of three regulated phosphorylation sites. TH synthesis rate was measured by dihydroxyphenylalanine (DOPA) accumulation in the presence of NSD-1015, an inhibitor of aromatic amino acid decarboxylase. TH-P was increased markedly by light or after intraocular injection of GABA(A) and glycine inhibitors. All three phosphospecific antibodies responded similarly to test drugs or light. A 30 min exposure to light increased DOPA accumulation by threefold over that seen after 30 min in darkness. Immunostaining to an anti-panNa channel antibody was found in all parts of the DA neuron. TTX blocked TH-P induced by light or GABA/glycine inhibitors but only in varicosities of the DA axon plexus, not in perikarya or dendrites. Veratridine increased TH-P in all parts of the DA neuron. The distribution of the monoamine vesicular transporter 2 was shown by immunocytochemistry to reside in varicosities of the DA plexus but not in dendrites, indicating that the varicosities are sites of dopamine release. Collectively, these data indicate that, in the retina, dopamine synthesis in varicosities is affected by the spiking activity of retinal neurons, possibly including that of the DA neurons themselves
PMID: 15115820
ISSN: 1529-2401
CID: 45999

Rho kinase regulates schwann cell myelination and formation of associated axonal domains

Melendez-Vasquez, Carmen V; Einheber, Steven; Salzer, James L
The myelin sheath forms by the spiral wrapping of a glial membrane around an axon. The mechanisms involved are poorly understood but are likely to involve coordinated changes in the glial cell cytoskeleton. Because of its key role as a regulator of the cytoskeleton, we investigated the role of Rho kinase (ROCK), a major downstream effector of Rho, in Schwann cell morphology, differentiation, and myelination. Pharmacologic inhibition of ROCK activity results in loss of microvilli and stress fibers in Schwann cell cultures and strikingly aberrant myelination in Schwann cell-neuron cocultures; there was no effect on Schwann cell proliferation or differentiation. Treated Schwann cells branch aberrantly and form multiple, small, independent myelin segments along the length of axons, each with associated nodes and paranodes. This organization partially resembles myelin formed by oligodendrocytes rather than the single long myelin sheath characteristic of Schwann cells. ROCK regulates myosin light chain phosphorylation, which is robustly, but transiently, activated at the onset of myelination. These results support a key role of Rho through its effector ROCK in coordinating the movement of the glial membrane around the axon at the onset of myelination via regulation of myosin phosphorylation and actomyosin assembly. They also indicate that the molecular machinery that promotes the wrapping of the glial membrane sheath around the axon is distributed along the entire length of the internode
PMID: 15102911
ISSN: 1529-2401
CID: 42681

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease

Lustbader, Joyce W; Cirilli, Maurizio; Lin, Chang; Xu, Hong Wei; Takuma, Kazuhiro; Wang, Ning; Caspersen, Casper; Chen, Xi; Pollak, Susan; Chaney, Michael; Trinchese, Fabrizio; Liu, Shumin; Gunn-Moore, Frank; Lue, Lih-Fen; Walker, Douglas G; Kuppusamy, Periannan; Zewier, Zay L; Arancio, Ottavio; Stern, David; Yan, Shirley ShiDu; Wu, Hao
Mitochondrial dysfunction is a hallmark of beta-amyloid (Abeta)-induced neuronal toxicity in Alzheimer's disease (AD). Here, we demonstrate that Abeta-binding alcohol dehydrogenase (ABAD) is a direct molecular link from Abeta to mitochondrial toxicity. Abeta interacts with ABAD in the mitochondria of AD patients and transgenic mice. The crystal structure of Abeta-bound ABAD shows substantial deformation of the active site that prevents nicotinamide adenine dinucleotide (NAD) binding. An ABAD peptide specifically inhibits ABAD-Abeta interaction and suppresses Abeta-induced apoptosis and free-radical generation in neurons. Transgenic mice overexpressing ABAD in an Abeta-rich environment manifest exaggerated neuronal oxidative stress and impaired memory. These data suggest that the ABAD-Abeta interaction may be a therapeutic target in AD
PMID: 15087549
ISSN: 1095-9203
CID: 132229